Deep Tech Startups

Evozyne designs and builds engineered protein therapeutics using an AI-native platform, focusing on treatments for immune-mediated diseases. The company develops novel biologics and a pipeline of engineered proteins aimed at clinical use.

5 investors

EVQLV develops a computational platform for antibody discovery that uses machine learning and computational biology to accelerate and reduce the cost of generating fully-human antibodies for drug development. The platform serves pharmaceutical and biotech partners working on antibody therapeutics.

5 investors

Excelsior Sciences develops automated chemistry technology for small-molecule discovery and manufacturing, targeting pharmaceutical and materials development. Its proprietary Blocc Chemistry platform uses AI-guided synthesis to accelerate drug discovery through machine-readable chemical building blocks and closed-loop learning.

5 investors

Exogene is a techbio startup using a generative AI and deep learning platform to discover novel, high-affinity TCR-based (T-cell receptor) therapies for treating solid tumors. It develops cell therapies aimed at cancer treatment by mining the TCR sequence space to identify safe, non-cross-reactive receptors against shared tumor targets.

5 investors

Exum develops the Massbox, a laser ablation laser ionization (LALI) analytical instrument for scientific labs that improves ionization efficiency and ease of use. The company serves research scientists and laboratory professionals seeking more reliable and portable mass spectrometry equipment.

5 investors

fab2 designs and builds semiconductor fabrication equipment and the fabs themselves, developing the hardware, components, and software needed to manufacture chips. It also builds Studio, an in-browser EDA tool for chip design, and uses automation for process engineering.

5 investors

Falcomm is a fabless semiconductor company that designs RF power amplifiers, including its Dual-Drive power amplifier technology, aimed at higher output power, wider bandwidth, and lower heat for mmWave applications. It serves the satellite communications, telecom, defense, and consumer markets, offering both mass-produced RFICs and custom designs, with products designed and manufactured in the USA.

5 investors

FastLabel operates a data engine for AI systems that handles data collection, annotation, and foundation model R&D in a single workflow. It focuses on data-centric AI using multimodal, site-specific data for AI development teams.

5 investors

Atomos Systems develops general-purpose humanoid robots with human-level dexterity and intelligence intended to perform physical labor and operate in the physical world. The company focuses on embodied intelligence and robotics for applications such as building infrastructure and automating complex tasks.

5 investors

Cell Microsystems develops laboratory instruments and platforms for cell engineering, culture, isolation, and analysis, including single-cell sorting, 3D cell culture, cell counting, tissue dissociation, and automated electrophysiology. Its tools serve life-science researchers and biopharma labs working on cell line development, drug discovery, and organoid/stem cell research.

5 investors

FMC is a semiconductor company developing non-volatile memory solutions, spun from EU research institutions with R&D and manufacturing operations across Europe, the US, Japan, and Taiwan. The company focuses on energy-efficient memory technologies for integrated system applications.

5 investors

FocalPoint develops positioning and navigation technology that improves accuracy beyond radio-based systems for everyday applications. The company provides GNSS-enhancing software and licensing solutions serving the automotive and broader navigation industries.

5 investors

Gaussion develops magnetic battery control technology that improves charging speed, heat generation, and lifetime performance across different cell formats and chemistries for electric vehicles, stationary storage, and industrial applications.

5 investors

GEMESYS develops energy-efficient AI training hardware using analog circuit emulation and memristors to replace gradient-based learning, enabling AI training on edge devices. Its EMULAITE project, built with Ruhr University Bochum's Chair for Production Systems, aims to make AI training significantly more energy-efficient and reduce the environmental impact of data centers.

5 investors

Geminus builds physics-native AI systems that understand, predict, and optimize complex industrial infrastructure in real time by combining physics-based simulation with real-world data and uncertainty-aware reasoning. The company serves energy, industrial, space, and defense sectors with mission-critical system optimization and monitoring.

5 investors

Gendo provides an AI-native collaborative workspace for architecture teams to generate, iterate, and make visual decisions within their design workflow. The platform targets design studios and teams of 2–50 who need to accelerate visual decision-making without relying on outsourced visualization pipelines.

5 investors

General Control is developing programmable, multiplexed epigenetic editing therapies designed to control the expression of several genes at once. It targets complex diseases with many interacting phenotypes, such as Alzheimer's and sarcopenia.

5 investors

Generate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering. The company creates new drugs on demand across diverse biologic modalities for immunology, oncology, infectious disease, and vaccines.

5 investors

Genesis AI develops general-purpose humanoid robots powered by its own foundation model, aimed at performing physical tasks across factories, laboratories, hospitals, and homes. It also builds a full-stack simulation platform to accelerate robot training.

5 investors

Georgiamune is a biopharmaceutical company developing targeted immunomodulator drugs that activate or down-modulate immune signaling pathways to treat cancer and autoimmune diseases. It operates a target discovery platform that supports a pipeline of first-in-class assets.

5 investors

Gibran is developing a general-purpose discovery engine that uses AI modeled on evolutionary biology and collective, population-based intelligence to generate its own data and solve problems where information is sparse or causally opaque. The company aims to apply this approach to research and discovery across complex, high-impact domains.

5 investors

A launch services company that develops vehicles and satellite systems for space missions. Gilmour Space serves customers requiring access to orbit through proprietary launch vehicle and satellite capabilities.

5 investors

Glass Imaging develops AI-based image processing technology aimed at bringing DSLR-quality photography to smartphone cameras. The company operates in the artificial intelligence and imaging space.

5 investors

Google DeepMind is an AI research lab, formed by combining Google Brain and DeepMind, that develops general AI systems and works toward artificial general intelligence. Its research has produced breakthroughs across reinforcement learning, protein structure prediction, language models, robotics, and generative AI.

5 investors